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Abstract 
 
 
 
Dysfunctions in cellular mechanisms such as apoptosis and autophagy have been 
implicated in the neurodegeneration associated with Alzheimer’s disease (AD).  
Autophagy in AD pathogenesis has been linked to the endosomal-lysosomal system, 
which has been shown to play a role in amyloid processing.  Studies have suggested that 
apoptosis may contribute to the neuronal cell loss observed in AD; however, there is no 
evidence of the apoptotic process leading to terminal completion.  Aβ1-42 has been 
shown to induce apoptosis in neurons and may be an initiating factor in AD.  Our 
previous studies demonstrated that neurons infected with C. pneumoniae are resistant to 
apoptosis, and that Aβ1-42 was increased by the infection.   Additionally, studies have 
demonstrated the interactions of several pathogens on the autophagic pathway.  The focus 
of the current studies was to determine if there is a relationship between the molecular 
mechanisms interconnecting autophagy and apoptosis following C. pneumoniae infection 
in neuronal cells that could lead to the pathologies observed in AD.  SKNMC neuronal 
cells obtained from ATCC were infected with the AR39 strain of C. pneumoniae at an 
MOI=1 for 24hrs to 72hrs and were analyzed using Real-time PCR arrays from 
SABiosciences specific for autophagy and apoptosis markers.  At 24hrs, neuronal cells 
infected with C. pneumoniae resulted in down-regulation of apoptosis and autophagy 
gene regulation.  Neuronal cells infected at 72hrs with C. pneumoniae up-regulated the 
expression of several genes associated with autophagy and apoptosis.  For example, 
BECN1 and ATG4C, both prominent genes in the autophagy pathway were 3.66 to 25.77 
fold down-regulated at 24hrs and increased 1.53 to 1.73 fold 72hrs post-infection,  
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respectively.  Similarly, apoptosis gene expression such as that for BAK1 was increased 
from -1.15 fold at 24hrs to 2.09 fold at 72hrs post-infection.  Our data suggest that  
C. pneumoniae exerts a control over changes in gene regulation affecting the apoptotic 
and autophagic processes in neuronal cells.  As both autophagic and apoptosis 
dysfunction have been observed in AD, the impairment of these normal cellular processes 
by a pathogen such as C. pneumoniae may contribute to the neuropathology seen in AD.  
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Chapter 1: Introduction 
 
 
 
1.1 Alzheimer’s disease 
Alzheimer’s disease (AD) is a neurodegenerative disorder that leads to a loss of 
memory and cognitive function in the elderly.  Changes in behavior and personality are 
also predominant symptoms in AD patients (1).  Age is one of the major risk factors for 
AD, and individuals over 80 years of age are at the greatest risk for developing AD (2).  
AD is classified as either sporadic, also referred to as late onset, or the familial form. 
Sporadic AD usually occurs in individuals 65 years of age or older, and affects ~50% of 
Americans who are 85 years and older (1), whereas familial AD occurs in 2% to 5% of 
AD cases. Familial AD can manifest during a person’s thirties, forties, or fifties (1), and 
is associated with genetic mutations, such as mutations in the genes encoding the amyloid 
precursor protein (APP), presenilin-1 and presenilin-2 proteins (3).   
A confirmed diagnosis of AD cannot be made until a histological examination of 
the patient’s brain is performed at autopsy.  At the macroscopic level, it is very difficult 
to distinguish the brain of an AD patient from a non-AD patient of the same age because 
many of the gross anatomical structures are similar.  For example, an aging brain and an 
AD brain will present with enlarged sulci and atrophied gyri.  Although, if the 
hippocampus has undergone much atrophy, and there is an enlargement of the temporal 
horn, these abnormalities together may be indicative of AD.  However, microscopic 
examination of the brain is used to determine if AD is the proper diagnosis (4).   
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1.2 Hallmark Pathologies associated with Alzheimer’s disease 
Two hallmarks of AD are the presence of neurofibrillary tangles and neuritic 
senile plaques (2), which are initially found in the entorhinal cortex and hippocampus of 
AD brains (1).  Neurofibrillary tangles (NFTs) are thick, abnormal fibrils that form in the 
cell bodies of neurons. Paired helical filaments are the major protein structure that 
collectively forms the NFTs (5).  The paired helical structures consist mainly of tau, a 
protein that is associated with microtubules (6).  The tau protein is hyperphosphorylated 
in the paired helical filaments and is formed into neurofibrillary tangles (NFTs) (7).  
Tranglutaminase has been implicated in the formation of NFTs by enzymatically 
crosslinking tau into the insoluble filamentous NFT structures (8).  
Neuritic senile plaques are found in the extracellular space that surrounds neurons 
(9).  The β-amyloid (Aβ) peptide is the main constituent of neuritic senile plaques (10).  
The proteolytic cleavage of amyloid precursor protein (APP) can result in the formation 
of Aβ (11) and can be cleaved through the non-amyloidogenic pathway or the 
amyloidogenic pathway (12).  In the non-amyloidogenic pathway, APP is cleaved at the 
plasma membrane by α-secretase to form soluble APP (APPsα) and a C-terminal 
fragment that is 83 amino acids long (C83).  At the endosome membrane, C83 is cleaved 
by γ secretase to form p3, a derivative of the beta-amyloid peptide, and the intracellular 
amyloid precursor protein cytoplasmic/C-terminal domain (12).  In the amyloidogenic 
pathway, APP is taken into the cell via endocytosis.  The cleavage of APP by β-secretase 
at the endosome membrane results in the formation of the secreted ectodomain, APPsβ, 
and a C-terminal fragment that is 99 amino acids long, C99 (12).  C99 is then cleaved by  
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γ-secretase to form Aβ40 and Aβ42 (12, 13).  Aβ40 is more commonly produced than Aβ42, 
however, Aβ42 is more toxic than Aβ40 (10, 11).  The cleavage products, APPsβ, Aβ40, 
and Aβ42 are secreted out of the cell to form amyloid plaques (12).  The predominant 
form of Aβ found in the neuritic senile plaques is Aβ42 (10).   
Current research indicates that sequential cleavage of the APP by ε-secretase and 
then γ-secretase also results in the formation of Aβ.  The cleavage of APP by ε-secretase 
results in Aβ49 and Aβ48, which when cleaved by γ-secretase forms the products Aβ46 and 
Aβ43 from Aβ49, and Aβ45 from Aβ48.  Cleavage of Aβ46 and Aβ43 by γ-secretase then 
results in Aβ40, and Aβ42 is formed when Aβ45 is cleaved by γ-secretase (11).   
Recently, mitochondrial dysfunction has been described as a feature characteristic 
of neurons and astrocytes of postmortem AD brains.  Studies have found that 
mitochondria in brains from AD patients experienced oxidative stress (14).  Some studies 
also suggest that the mitochondrial membranes in the neurons of AD patients contained a 
buildup of Aβ oligomers.  These investigations suggest that essential proteins cannot pass 
through the mitochondrial membranes containing Aβ oligomers, which would result in 
dysfunction of the electron transport chain, an increase in reactive oxygen species, and 
changes in the structure of the mitochondria (14, 15).  A reduction in the number of 
mitochondria that function appropriately in neurons, especially in the terminal regions of 
neurons, may contribute to poor transmission between neurons that could result in a 
decrease in cognitive function (14, 15).   
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1.3 Apoptosis 
Mitochondrial dysfunction can lead to apoptosis, a form of cell death.  Apoptosis 
occurs at regulated levels in the cells of the body; however, if apoptosis becomes 
unregulated and decreases or increases too much within specific cells, such as neuronal 
cells, apoptosis could be associated with diseases, such as AD.  A cell that is undergoing 
apoptosis exhibits specific characteristics including condensation of chromatin, shrinkage 
of the cell, bleb formation, and nicking of the DNA.  Caspases are active upon initiation 
of apoptosis in a cell and is a characteristic that is associated with apoptosis (16).   
Apoptosis can be initiated by various stimuli acting on different receptors (17).  
The more common pathways include the death receptor pathway and the mitochondrial 
pathway.  The activation of a death receptor by a death ligand stimulates caspase-8, 
which then cleaves the Bid protein or caspase-3; an effector caspase that induces 
apoptosis.  The activation of the Bid protein leads to the activation of the Bax and Bak 
proteins, which will result in cytochrome c being released from the mitochondria.  The 
release of cytochrome c leads to the activation of caspase-9, which also will cleave 
caspase-3 to result in the stimulation of apoptosis (17).   
 
1.4 Forms of Autophagy 
In some instances, cells may activate the autophagy pathway instead of, or before, 
initiating apoptosis (18).  An increase in the number of autophagic vacuoles (AVs) has 
been identified in neurons from AD brains implicating autophagy as a pathological 
process in AD (19).  There are three different forms of autophagy, all of which result in  
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the lysosomal degradation of proteins and organelles.  In microautophagy, the 
cytoplasmic components of a cell are engulfed by lysosomal membranes.  Chaperone-
mediated autophagy occurs when proteins with a KFERQ-like peptide motif are imported 
directly across the lysosomal membrane.  Macroautophagy is a process where the 
cytoplasm and its constituents within a cell are engulfed by a double-membrane structure 
referred to as an autophagosome (18).  The formation of an autophagosome is 
coordinated by complexes consisting of autophagy gene (ATG)-related proteins (20).  
Autophagosome formation occurs within the synapses and neuritic processes of neurons.  
Because lysosomes are most commonly found in the neuronal cell bodies, in order for an 
autophagosome to fuse with a lysosome, retrograde transport of the autophagosome to the 
cell body of the neuron must be efficient (21).  The lysosomal hydrolases within the 
lysosome will then degrade the contents of the autophagosome (18, 20, 22).  The proteins 
and other substances that are broken down by lysosomal hydrolases can be used for other 
cell processes or energy requirements (18, 19, 22).  Macroautophagy is the form of 
autophagy most commonly studied (18).   
 
1.5 Autophagy and the Endosomal-Lysosomal System 
Autophagy is associated with the endosomal-lysosomal system since 
autophagosomes will fuse with late endosomes or lysosomes (22).  Studies have found 
that the activity of the lysosomal system is enhanced in patients with AD by observing an 
increase in the production of hydrolases present in lysosomes (23).  The lysosomal 
system is also related to the endosomal pathway since early endosomes that are formed  
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will develop into late endosomes, which exchange their content or fuse with lysosomes 
(21).  Neurons from AD brains have been found to exhibit enlarged early endosomes.  
This is significant in AD because early endosomes take in proteins, such as 
apolipoprotein E and APP, and it has been determined that Aβ is formed in early 
endosomes (23).  The formation of Aβ has also been observed within AV’s.  The 
accumulation of AV’s in the AD brain, possibly because of impaired AV clearance and 
autophagy induction, may therefore promote the accumulation of Aβ (21). 
 
1.6 Autophagic Vacuole Pathology in Alzheimer’s disease 
The autophagic vacuole pathology observed in AD has been compared to that 
seen in autophagic dysfunction during various stages of the autophagy pathway in 
primary rat cortical neurons.  While the induction of autophagy alone by rapamycin did 
not result in AV pathology similar to that observed in AD brains, AD-like AV pathology 
was seen to result from impaired clearance of AV’s after treatment with vinblastine or 
leupeptin.  Vinblastine treatment was shown to slow the fusion of autophagosomes with 
lysosomes; and leupeptin, a protease inhibitor, inhibits the degradation of proteins in 
lysosomes (24).  Clearance of autophagosomes is also impaired when their retrograde 
transport to the neuronal cell body for fusion with lysosomes has been impaired as has 
been observed in AD (21).  The impaired clearance of AV’s, alone or in combination 
with induction of autophagy, can produce an AV pathology which is similar to that 
observed in the AD brain (24).    
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1.7 Autophagy Signaling Pathways 
 The process of autophagy is regulated by two main signaling pathways; each 
acting on the mammalian target of rapamycin (mTOR) kinase, a serine/threonine kinase 
(25), which is an important regulator of autophagy (20).  There is a decrease in autophagy 
when stored amino acids and growth factors, such as insulin, are increased.  In one 
signaling pathway, AMP-activated protein kinase (AMPK) is inhibited when there is an 
increase in the concentration of intracellular amino acids.  This results in the TSC1/TSC2 
complex not being active, since AMPK activates the TSC1/TSC2 complex.  The activity 
of the GTP-binding protein Rheb will therefore be increased when the TSC1/TSC2 
complex is inactive, which results in the activation of mTOR kinase to inhibit autophagy 
(20).    
Growth factors signal the second pathway that regulates autophagy by activation 
of the Class I phosphatidylinositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) pathway, 
which also leads to a decrease in autophagy by activating mTOR kinase (20).  The 
activation of the Class I PI3K-Akt/PKB pathway via growth factors inhibits the tuberous 
sclerosis complex (TSC1/TSC2) by stimulating phosphorylation, which results in the 
Rheb protein being active.  The active form of Rheb will activate mTOR kinase, which 
results in a decrease in autophagy (18, 20).  
There are specific kinases, such as mTOR kinase, that function through 
phosphorylation of protein complexes involved in the induction or inhibition of 
autophagy.  For instance, when mTOR kinase is active it phosphorylates the ULK 
complex in order to inhibit the complex from inducing autophagy.  The ULK complex  
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consists of the ULK1 and ULK2 kinases.  The inhibition of mTOR kinase allows the 
ULK complex to be active, which induces autophagy (18).   
The next complex to be activated in the autophagy pathway, the Beclin1-Class III 
PI3K complex, which requires the interaction and activation of the proteins UVRAG, 
Atg14, and Ambra1.  The active form of the Beclin1-Class III PI3K complex consists of 
PI3-P-enriched membrane domains, which interact with proteins such as LC3, Atg9, and 
the Atg5-12-16 complex.  These proteins are needed for the formation of an 
autophagosome.  Another protein that is involved in autophagosome formation is Bif-1, 
which interacts with UVRAG and the Beclin1-Class III PI3K complex.  Bif-1 has been 
found to result in the curving of membranes, and may be associated with the development 
of the autophagosome membrane (18).    
Proteins such as Bcl2, Beclin 1, p53, Atg5, Atg4d, and the DAP kinases have 
been found to interact with proteins in both the autophagy and apoptosis pathways (18, 
25).  For instance, the anti-apoptotic Bcl2 protein can bind to the BH3 domain of the 
Beclin 1 protein and prevent Beclin 1 from inducing autophagy (18).  The p53 protein is 
known to induce apoptosis; however, under physiological stress p53 has also been found 
to increase the rate of expression of the DRAM gene, and can inhibit mTOR through 
AMPK to induce autophagy (25).  Both Atg5 and Atg4d are proteins involved in 
autophagy that can be cleaved, which results in these proteins inducing apoptosis after 
moving to the mitochondria (18, 25).  The DAP kinases are known to regulate apoptosis 
through phosphorylation and DAP kinase will also phosphorylate Beclin 1, which 
decreases Beclin 1’s binding to Bcl-2 so that autophagy may be induced (18).                        
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1.8 Neuroinflammation 
Another characteristic seen in the brains of AD patients is neuroinflammation 
(26).  Neuroinflammation has also been associated with other neurodegenerative 
disorders.  When glial cells in the brain are continually activated, neuroinflammation 
occurs.  The activation of glial cells results in the release of proinflammatory mediators, 
which are thought to be involved in the pathology of AD.  The Aβ peptide contained in 
the senile plaques that are associated with AD have been found to attract microglial cells, 
which are a type of activated glial cell.  The increased expression of tryptophan 
metabolites has also been observed in AD, which results in the presence of IgA 
antibodies in the serum to the tryptophan metabolites.  The increased expression of 
tryptophan metabolites occurs when the indoleamine 2,3-dioxygenase (IDO) pathway is 
activated (27).            
 
1.9 Chlamydia pneumoniae         
Infection with C. pneumoniae and other microorganisms, such as herpes simplex 
virus type 1, can promote pathology that is associated with sporadic AD (28).  Amyloid 
plaques, similar to those found in AD brains, were identified in the brains of BALB/c 
mice following infection with C. pneumoniae (29).  Inflammation also occurred in these 
brains after infection with Chlamydia pneumoniae.  Studies have shown that C. 
pneumoniae DNA is found in AD brain tissue samples taken postmortem, than from brain 
tissue samples of people who did not present with AD pathology (28).  C. pneumoniae is 
thought to enter the host’s brain through the olfactory tract and/or the blood brain barrier.   
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Using PCR and RT-PCR, it was determined that C. pneumoniae was present in the 
olfactory bulbs and cells that are located near blood vessels of post-mortem AD patients 
(30).   
C. pneumoniae is an obligate intracellular bacterium that infects the respiratory 
tract.  C. pneumoniae was originally referred to as TWAR, which is a combination of the 
two codes, TW-83 and AR-39, used to identify the first C. pneumoniae isolates (31).  C. 
pneumoniae has a biphasic life cycle that begins with an elementary body attaching to the 
host cell and entering the host cell through endocytosis.  The elementary body is the 
infectious form of C. pneumoniae that is metabolically inactive.  In the endosome, the 
elementary bodies can form an inclusion and become reticulate bodies, which are not 
infectious and are metabolically active.  The reticulate bodies replicate and are then 
converted back to elementary bodies.  After approximately 48hrs to 72hrs the elementary 
bodies are released by lysis of the host cell (32).  
 
1.10 Evidence of Effects of Chlamydia pneumoniae on Apoptosis and Autophagy 
The effects of infection with different species of Chlamydia on the processes of 
apoptosis in monocytes and neuronal cells and autophagy in cervical carcinoma HeLa 
cells have been studied (33, 34, 35).  In monocytes it was found that Chlamydia 
pneumoniae infection leads to the activation of NF-κB, which results in the inhibition of 
apoptosis (33).  Similarly, when neuronal cells were infected with C. pneumoniae and 
then treated with staurosporine to induce apoptosis, apoptosis was inhibited (34).  In 
contrast, autophagy was induced following infection of cervical carcinoma HeLa cells  
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with Chlamydia trachomatis for 24hrs, which was thought to be due to low nutrient 
levels in the infected cells (35).   
 
1.11 Proposed Studies  
Mitochondrial dysfunction and the initiation of the apoptotic process have been 
observed in the pathology in AD brains (16).  However, there is a lack of evidence 
demonstrating that apoptosis has advanced to completion within the neuronal cells in AD. 
Since C. pneumoniae has been implicated as a trigger in the development of AD 
pathology and has been shown to inhibit apoptosis (34), these studies focused on 
investigating an alternate pathway that may be initiated by C. pneumoniae in the infected 
cell. Autophagy may be the alternative pathway that is up-regulated in an attempt to 
maintain a state of homeostasis within the neuronal cell.  
There’s a complex relationship between autophagy and apoptosis in a cell’s 
adaptation in avoiding cellular death (25).  Naturally evolving cellular mechanisms for 
survival may override the self-destructive apoptosis pathway by alternatively inducing 
autophagy.  The induction of the autophagy pathway is a survival response for the cell in 
a highly regulated cellular process by gene and protein regulation to eliminate damaged 
organelles and proteins that would be detrimental to the cell.  Interestingly, intracellular 
pathogens, such as different species of Chlamydia, have been shown to alter the apoptosis 
pathway and the autophagy pathway to ensure survival of the host cell (33, 34, 35).  
Therefore, our experiments were designed to see what effects Chlamydia pneumoniae has 
on autophagy and apoptosis in neuronal cells, which have both been implicated in AD.    
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We hypothesize that infection with C. pneumoniae in neuronal cells may exert 
pressure inducing autophagy as seen in AD.  In our experimental paradigm, changes in 
gene expression following an infection with C. pneumoniae were measured using RT
2
- 
PCR arrays specific for autophagy and apoptosis.  SKNMC neuronal cells were infected 
with Chlamydia pneumoniae at an MOI = 1 for 24hrs and 72hrs in this study.  The 
experiments were performed in triplicate for both uninfected and infected samples that 
were run on the arrays for each time point, and uninfected samples were run on the RT
2
- 
PCR arrays as controls.   
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Chapter 2: Materials and Methods 
 
 
 
2.1 Tissue Culture 
 SKNMC neuronal cells (Cat. # HTB–10 - ATCC) were cultured in growth media 
(GM) containing Minimum Essential Medium Eagle (Cat. # 30-2003 - ATCC) and 10% 
FBS. Cells were maintained at 37°C in 5% CO2.  For propagation, neuronal cells were 
grown in T25 corning flasks (Cat. # - 430639) in a total volume of 8mL GM. For the 
infection assays, cells were plated at 5.0 x 10
4 
for the 72hr
 
infection, and 2.0 x 10
5 
to 5.0 x 
10
5 
for the 24hr infection in 6 well culture plates (Cell Star, Cat. # 657 160). Cells were 
grown to a confluency of approximately 50% at which time the cells exhibited a neuronal 
morphology.   
 
2.2 Establishment of Cell Counts 
Cell counts were established for an infection with the AR39 strain of Chlamydia 
pneumoniae (C. pneumoniae) (Cat. # 53592 – ATCC) by trypsinizing (Cat. # 15400-054 - 
Gibco) one of the wells in the 6 well plate, and neutralizing the trypsin with GM.  The 
cells were pelleted by centrifuging at 1,000X g in the Spectrafuge (Cat. # C2400-P -24D 
Labnet) for 5 minutes at room temperature (RT).  The supernatant was removed and the 
cells are resuspended in 1ml of GM.  10µl of cells were mixed with 10µl of trypan blue 
(Cat # T1082, 837949- Invitrogen) and were counted using the Countess automated cell 
counter (Cat # C10281- Invitrogen).   
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2.3 Infection of neuronal cells with Chlamydia pneumoniae  
All infections of neuronal cells were performed at an MOI (multiplicity of 
infection) = 1 with C. pneumoniae in 6 well plates once the cells were grown to a 50% 
confluency displaying a neuronal morphology.  At the start of each infection, GM was 
removed from each well, and 1ml of fresh GM was added to each well.  At this point, 
cells that were to remain uninfected were incubated at 37°C in 5% CO2 for 24 or 72 hrs. 
A total volume of 1mL, comprised of GM and the appropriate concentration of C. 
pneumoniae, was added to the wells for the infection assay.  The C. pneumoniae was 
thawed, sonicated for 1 minute, and vortexed for 1 minute, and then added directly to the 
wells.  The infected 6 well plate was then inserted into a biohazard bag and centrifuged at 
RT for 30 minutes at 1,000X g in the Sorvall Legend RT.  Following centrifugation, the 
cells were incubated at 37°C in 5% CO2 for 24 or 72 hrs.  For the 72hr time point, 1ml of 
GM was added to the infected and the uninfected wells 24hrs after initiation of the 
infection with C. pneumoniae.  Following incubation, GM was removed, and the cells 
were rinsed in Hank’s Balanced Salt Solution (HBSS) (Cat. # 30-2213 – ATCC) prior to 
processing for RNA extraction and immunocytochemistry.  
 
2.4 Apoptosis Induction with Staurosporine 
For apoptosis induction at 24 and 72 hrs post-infection in both uninfected and 
infected cells in the 6 well plates, the GM was removed.  A 1mL solution of 1µM 
staurosporine (Cat. # 078K4057, S6942 - Sigma) in GM was added, and then incubated 
for 3hrs at 37°C in 5% CO2.  Following incubation, GM containing the staurosporine was  
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removed, and the cells were rinsed in MEM (ATCC) prior to processing for RNA 
extraction and immunocytochemistry.  
 
2.5 Screening for Chlamydia pneumoniae infection by Immunocytochemistry 
 Cells grown in 6 well plates from 8.0 x 10
5
 to 1.5 x 10
6
 were detached with 700µl 
of trypsin and neutralized with 700µl of GM to remove the cells from the wells.  The 
cells were then pelleted at 1000X g in the spectrafuge for 5 minutes at RT.  The 
supernatant was discarded and the pellet was resuspended in 1mL of GM.  500µl of GM 
containing the cells were transferred into EZ Single cytofunnels (Cat. # A78710020 
Shandon- ThermoScientific) containing adhesive glass slides (Cat. # 7255/90 - Starfrost), 
and were cytospun with the Thermoshandon Cytospin3 (Cat # 74000222 Issue 8) for 4 
minutes at 32X g.  The glass slide was removed and the cells were fixed in 
cytofix/cytoperm (BD Biosciences #554722) for 30 minutes.  The cells were rinsed twice 
with PBS, and then blocked in 500µl of 1X perm/wash (Cat. # 51-2091KZ – 554723 – 
BD Biosciences) for 30 minutes.  The cells were rinsed 2X with PBS (Cat. # P3813 – 
10PAK – 109K8210), then once with molecular grade water.  The cells were incubated at 
37° C for 1 hour in FITC conjugated C. pneumoniae antibody 61C75 (Fitzgerald) diluted 
in PBS at 1:100.  The cells were rinsed with PBS twice, and then rinsed 5X with 
molecular grade water.  The cells were coverslipped using mounting media containing 
DAPI (Cat. # 17985-51 - EMS Fluoro Gel II).   
Slides were viewed on a Nikon 90I and captured with Kodak element program.  
The neuronal cells that were infected with C. pneumoniae were counted to determine the  
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percentage of cells infected at each time point.  For the 24hr time point, cells were 
counted on slides from three different 24hr infections.  There were three to four slides for 
each 24hr infection.  One field of cells from each slide was counted.  In each field for the 
24hr infections, there were 26 to 98 total cells.  For the 72hr time point, cells were 
counted on slides from two different 72hr infections.  There were two slides for each 72hr 
infection.  Similar to the 24hr time point, one field of cells from each slide was counted 
for the 72hr time point.  In each field for the 72hr infections, there were 37 to 99 total 
cells.       
 
2.6 Processing for RNA Extraction 
Media was removed from infected or uninfected cells grown in the 6 well plates.  
A set of cells were then treated with staurosporine for 3 hours.  The cells were rinsed with 
either HBSS or MEM and then incubated with 700µl of trypsin for 3 minutes followed by 
the addition of 700µl of GM.  The solution of cells from each well was centrifuged in 
microcentrifuge tubes for 5 minutes at 1,000X g in the spectrafuge.  Following 
centrifugation, the supernatants were removed and the cells were resuspended in HBSS.  
Cell counts were obtained from each well to ensure a cell count of at least  
4.0 x 10
5 
for the RNA extraction.  Following cell counts, the cells were pelleted at 
1,000X g in the spectrafuge for 5 minutes.  The supernatants were discarded and the 
pellets were chilled on ice and then stored at -80°C prior to RNA extraction.    
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2.7 RNA Extraction 
All RNA extraction and cDNA protocols were performed in the PCR hood 
(AirClean 600PCR Workstation – ISC BioExpress).  All reagents and equipment were 
cleaned with an RNaseZap wipe (Cat. # AM9786) prior to being put in the PCR hood.  
All centrifugations were performed in the spectrafuge.  350µl of Buffer RLT (RNeasy 
Mini Kit (50) Cat. # 74104 – Qiagen) was added to the pelleted cells that had been 
previously frozen at -80°C, and then vortexed.  The lysate was pipetted into a 
QIAshredder spin column placed in a 2 mL collection tube (QIAshredder (50) Cat. # 
79654 – Qiagen) and centrifuged in the spectrafuge for 2 minutes at 16,300X g. The 
QIAshredder spin column was discarded and 350µl of 70% ethanol was mixed with the 
homogenized lysate in the collection tube.  700µl of the homogenized lysate was 
transferred to an RNeasy spin column placed in a 2ml collection tube (RNeasy Mini Kit 
(50) Cat. # 74104 – Qiagen).  The sample was then centrifuged in the spectrafuge for 15 
seconds at 11,200X g.  The flow through was discarded and 350µl of Buffer RW1 
(RNeasy Mini Kit (50) Cat. # 74104 – Qiagen) was added to the RNeasy spin column to 
wash the spin column membrane.  The sample was centrifuged for 15 seconds at 11,200X 
g in the spectrafuge, and the flow through was discarded.   
An optional DNase digestion was performed to eliminate genomic DNA 
contamination.  70µl of Buffer RDD and 10µl of DNase I stock solution (RNase-Free 
DNase Set (50) Cat. #79254 – Qiagen) (RNase-Free DNase Set (50) Cat. # 79254 – 
Qiagen) was added into a 0.5ml PCR tube (Cat. # AM12275 – Ambion).  This DNase I 
incubation mix was centrifuged for 15 seconds at 11,200X g in the spectrafuge.  80µl of  
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the DNase I incubation mix was then added directly to the RNeasy spin column 
membrane, and incubated at RT for 15 minutes.  350µl of Buffer RW1 was added to the 
RNeasy spin column, and the sample was centrifuged for 15 seconds at 11,200X g.  The 
flow through was discarded and 500µl of Buffer RPE (RNeasy Mini Kit (50) Cat. # 
74104 – Qiagen) was added to the RNeasy spin column to wash the spin column 
membrane.  The sample was centrifuged in the spectrafuge for 15 seconds at 11,200X g.  
500µl of Buffer RPE was added to the RNeasy spin column to wash the spin column 
membrane, and the sample was centrifuged for 2 minutes at 11,200X g.  Following 
centrifugation, the RNeasy spin column was carefully placed in a new 1.5ml collection 
tube (RNeasy Mini Kit (50) Cat. # 74104 – Qiagen), and 40µl of RNase-free water 
(RNeasy Mini Kit (50) Cat. # 74104 – Qiagen) was added directly to the spin column 
membrane.  The sample was centrifuged for 1 minute at 11,200X g to elute the RNA.   
 
2.8 Determination of RNA Yield 
 5µl of the RNA sample was mixed with 55µl of 10mM Tris pH 8, or 10µl of 
RNA sample was mixed with 990µl of 10mM Tris pH 8, and these samples were 
centrifuged for 5 – 10 seconds at 11,200X g.  The sample was then added to a quartz 
cuvette, either 60µl (Cat. # 14–385–928F – Fisher Scientific) or 1mL cuvette (Cat. # 14–
385–914A) for determination of the RNA concentration.  The samples were read with a 
spectrophotometer (Nicolet evolution 100 – ThermoScientific). The spectrophotometer 
was blanked with 10mM Tris pH 8, and the absorbancies were recorded at 260nm and 
280nm. The absorbancy at 260nm was used to determine the RNA yield with the  
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equation 44ug/ml x A260 x dilution factor; the dilution factor was 12 for the 60µl cuvette 
or 100 for the 1mL cuvette.  The absorbancies at 260nm and 280nm were used to 
calculate the ratio, A260/A280, which indicated if the sample had any protein 
contamination. A number between approximately 1.8 and 2.0 indicated that there was no 
protein contamination of the RNA sample.   
 
2.9 First Strand cDNA Synthesis 
 The RNA stock that had been stored at -80°C was used to prepare the cDNA for 
an RT
2
-PCR human autophagy PCR array (RT
2
 Profiler
TM
 PCR Array Human Autophagy 
– SABiosciences PAHS – 084A).  Approximately 1µg of RNA was used to generate the 
cDNA for each array.   
For the first strand cDNA synthesis, the determined amount of RNA sample and 
2µl of 5X gDNA Elimination buffer (RT
2
 First Strand Kit – cDNA Synthesis – Cat. # 
C03/330401 - SABiosciences) was added to a sterile 0.2ml PCR tube (Cat. # AM12225 - 
Ambion).  The nuclease-free water (Cat. # AM9930 – Ambion) was added to the PCR 
tube bringing the total volume of genomic DNA elimination mixture to 10µl.  The 
genomic DNA elimination mixture was centrifuged for 10 seconds at 6,000X g.  The 
mixture was incubated in the PCR machine (Techne TC-3000G) at 42°C for 5 minutes.  
Following incubation, the genomic DNA elimination mixture was chilled on ice for at 
least one minute.  For preparation of the RT cocktail (RT
2
 First Strand Kit – cDNA 
Synthesis – Cat. # C03/330401 - SABiosciences), 4µl of 5X RT Buffer 3 (BC3), 1µl of 
Primer & External Control Mix (P2), 2µl of RE3 (RT Enzyme Mix 3), and 3µl of  
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nuclease free water were added to a sterile 0.2mL PCR tube.  The 10µl of RT cocktail 
was added to the genomic DNA elimination mixture. The reaction was incubated in the 
PCR machine at 42°C for 15 minutes and the reaction was stopped by heating at 95°C for 
5 minutes.  Following heating, 91µl of nuclease free water was added to the cDNA and 
held on ice until the array was prepared or the cDNA was stored at -20°C overnight.  
 
2.10 Real-Time PCR Human Autophagy Arrays 
 The experimental cocktail was prepared by mixing 1,248µl of nuclease free water, 
102µl of diluted first strand cDNA synthesis reaction, and 1,350µl of 2X SABiosciences 
RT
2
 qPCR Master Mix (Cat. # PA-012-12 – SABiosciences) into a reservoir (Cat. # B-
0820-8 – BioExpress). The RT2-PCR array was opened in the PCR hood and placed in a 
PCR isofreezer.  An eight-channel pipettor was used to add 25µl of the experimental 
cocktail to each well of the PCR Array, one column at a time.  After addition of the 
cocktail to the column, the wells were sealed with an 8-cap strip.  The RT
2
-PCR array 
was centrifuged in the Sorvall Legend RT centrifuge for 3 minutes at RT and 1,000 rpm.  
Real-time PCR (RT-PCR) was performed using the Applied Biosystems Prism 7000 
Sequence Detection System to measure the PCR amplification from the autophagy array.   
 
2.11 Data Analysis 
For the data analysis, the changes in fold regulation of the autophagy and 
apoptosis gene profiles for the neuronal cells were determined for both time points by 
using SABiosciences PCR Web-Based Data Analysis.  The threshold cycle data from  
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each RT
2
-PCR array run was uploaded into SABiosciences PCR Web-Based Data 
Analysis website, which would convert the threshold cycle data into the values for the 
changes in fold regulation.  The threshold cycle data obtained from uninfected neuronal 
cells from each time point was used as the controls for the untreated infected neuronal 
cells for each time point, respectively.  The threshold cycle data obtained from uninfected 
neuronal cells treated with staurosporine from each time point was used as the controls 
for the treated infected neuronal cells for each time point, respectively.  For further 
analysis of apoptotic gene expression, infected neuronal cells were induced into apoptosis 
with 1µM staurosporine, which is a protein kinase C (PKC) inhibitor (36).  The changes 
in autophagy gene expression was also studied to see if infection with C. pneumoniae 
following staurosporine treatment would lead to induction of autophagy, since previous 
studies have shown that apoptosis is inhibited following C. pneumoniae infection (34). 
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Chapter 3: Results 
 
3.1 Verification of Infection by Immunocytochemistry 
 For verification of infection with C. pneumoniae, the neuronal cells were 
immunolabeled with FITC conjugated Chlamydial antibody 61C75A.  The percentage of 
infected cells was determined from counting profiles of cells containing a positive 
labeling for C. pneumoniae (Figure 1).  For the 24hr time point, 50% of the cells were 
infected, whereas 70% of the cells were infected at the 72hr time point (Figure 2).  For 
each time point that demonstrated satisfactory immunolabeling of C. pneumoniae, the 
RNA was extracted from the uninfected and infected neuronal cells and was converted 
into cDNA.  The uninfected neuronal cells were screened on the RT
2
-PCR arrays as 
controls for each time point.   
 
 
 
 
Figure 1. Neuronal cells immunolabeled with FITC conjugated Chlamydial antibody 
61C75A following infection with C. pneumoniae for 24hrs and 72hrs. Green represents 
the C. pneumoniae and blue is the nuclei of the cell. 
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Figure 2. Quantitation of  SKNMC neuronal cells that were infected with C. pneumoniae 
at 24hrs post-infection and 72hrs post-infection based on immunolabeling of cells with 
FITC conjugated Chlamydial antibody 61C75A. 
 
3.2 Apoptosis Genes 
 In neuronal cells infected with C. pneumoniae, as seen in figure 3 and table 1, a 
selection of key genes specific for apoptosis showed a downward trend in gene 
expression at the 24hr time point and an upward trend in gene expression at the 72hr time 
point.  The genes that demonstrate this trend are BAK1, BNIP3, CASP8, and NFKB1.   
The gene that demonstrated the most pronounced downward trend at 24hrs post-infection 
was NFKB1 with a 49.505 fold down-regulation.  However, the gene expression for 
NFKB1 was not as suppressed at 72hrs, but remained down-regulated by a factor of 
4.057.  Interestingly, the NFKB1 gene is typically up-regulated following a bacterial 
infection in other cell lines, such as monocytes (Dr. Balin & Charlie unpublished).  The 
BAK1 and BNIP3 genes encode proteins that contribute to apoptosis through the  
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mitochondrial pathway (37).  Alternatively, the CASP8 gene functions as an initiator 
caspase to induce apoptosis in the death receptor pathway.  The fold regulation of the 
BAK1, BNIP3, and CASP8 genes at 24hrs was between -1.0 and -2.2, whereas at 72hrs 
the range of fold regulation was between -1.1 and 2.1.  One of the genes that did not 
follow the previously described trend was the FAS gene, which encodes a death receptor 
that is a member of the TNF-superfamily (38).  The interaction of the Fas death receptor 
with proteins such as caspase 8 is involved with the initiation of the apoptotic pathway 
(38).  The fold regulation at 24hrs for the FAS gene was 4.298, and was decreased to 
3.295 at 72hrs. 
 
Table 1. Fold regulation of the key genes involved in apoptosis following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs. 
 
 
Fold Regulation of Apoptosis Genes 
  24hr inf 72hr inf 
BAK1 -1.150 2.096 
BNIP3 -1.437 1.722 
CASP8 -2.193 -1.130 
FAS 4.298 3.295 
NFKB1 -49.505 -4.057 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
 
 
 
Figure 3. Fold regulation of the key genes involved in apoptosis following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs. Genes with significant p-values 
are indicated with asterisks. 
 
 
 
3.3 Apoptosis Genes Following Staurosporine Treatment 
 
In order to differentiate the effects exerted by C. pneumoniae in neuronal cells on 
the pro-apoptotic genes, the neuronal cells were induced into apoptosis with 1µM 
staurosporine.  As seen in figure 4 and table 2, an incubation of the infected neuronal 
cells with staurosporine resulted initially, at 24hrs, in an up-regulation of the key genes 
involved in apoptosis, such as BAK1, BNIP3, CASP8, FAS, and NFKB1, followed by a 
decrease in fold regulation at the 72hr time point.  The most prominent change in gene 
expression occurred from 24hrs to 72hrs with the CASP8, FAS, and BNIP3 genes. At 
24hrs, the CASP8 gene increased by 3.595 fold, and then decreased to  
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-1.096 fold at 72hrs.  Similarly, the FAS gene had an 8.877 fold increase in expression at 
24hrs, which was suppressed to 1.432 fold at 72hrs.  Initially, the fold regulation for the 
BNIP3 gene was 1.555 at 24hrs, which decreased to -3.917 fold at 72hrs.  Interestingly, 
NFKB1 has a minimal change in gene expression from 24hrs to 72hrs in the presence of 
staurosporine.  A comparison between the infected neuronal cells and the infected 
neuronal cells treated with staurosporine as seen in figure 4, revealed a reversal in gene 
expression.  The effects exerted by C. pneumoniae specifically indicated that  
C. pneumoniae is suppressing the pro-apoptotic genes at 72hrs.  
 
Table 2. Fold regulation values for the key genes involved in apoptosis following 
infection of neuronal cells with C. pneumoniae for 24hrs and 72hrs. 
 
Fold Regulation - Apoptosis 
  24hr inf 72hr inf 24hr inf +stauro 72hr inf +stauro 
BAK1 -1.151 2.096 1.974 1.263 
BNIP3 -1.437 1.722 1.555 -3.917 
CASP8 -2.193 -1.130 3.595 -1.096 
FAS 4.298 3.295 8.877 1.432 
NFKB1 -49.505 -4.057 2.548 2.479 
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Figure 4. Fold regulation for the key genes involved in apoptosis following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs and treatment with staurosporine 
for 3hrs to induce apoptosis. Genes with significant p-values are indicated with asterisks. 
 
 
 
3.4 Autophagy Genes 
Since there is a commonality in the triggering mechanisms of apoptosis and 
autophagy, genes specific for autophagy were also screened following infection of 
neuronal cells with C. pneumoniae from 24hrs to 72hrs.  Some key genes involved in 
autophagy include ATG4C, ATG9A, BECN1, and DRAM.  The ATG4C, ATG9A and 
BECN1 genes encode proteins that are pivotal to autophagosome formation (39, 40).  The 
DRAM gene encodes a lysosomal protein that is a damage-regulated autophagy 
modulator (41).  The general trend in the expression of the autophagy genes was a  
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down-regulation at 24hrs post-infection and an up-regulation after 72hrs post-infection 
(Figure 5 and Table 3).  At 24hrs, the fold regulation for the ATG4C gene was -25.773, 
which was followed by an increase to 2.738 fold at 72hrs.  The fold regulation for the 
BECN1 gene was -3.662 at 24hrs, which increased to 1.532 fold at 72hrs.  The fold 
regulation for the DRAM gene was -2.680 at 24hrs and 1.575 at 72hrs.  There was a 
minimal change in gene expression for ATG9A.   
 
Table 3. Fold regulation values for the key genes involved in autophagy following 
infection of neuronal cells with C. pneumoniae for 24hrs and 72hrs.   
 
Fold Regulation of Autophagy Genes 
  24hr inf 72hr inf 
ATG4C -25.773 2.738 
ATG9A -1.067 1.637 
BECN1 -3.662 1.532 
DRAM -2.680 1.575 
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Figure 5. Fold regulation of the key genes involved in autophagy following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs. Genes with significant p-values 
are indicated by an asterisk.  
 
 
 
3.5 Genes involved in Autophagy Induction by Intracellular Pathogens 
 Genes that are involved in autophagy induction by intracellular pathogens, such as 
IFNA2, IFNA4, and IFNG, were analyzed following infection of neuronal cells with C. 
pneumoniae at 24hrs and 72hrs.  The IFNA2 and IFNA4 genes encode cytokines that 
stimulate immune cells (42).  The protein encoded by IFNG is a cytokine that activates 
macrophages (38).  At 24hrs, the IFNA4 and IFNG genes were slightly up-regulated, 
whereas the IFNA2 gene was slightly down-regulated.  Each of these genes was up-
regulated after 72hrs (Figure 6 and Table 4).  The IFNA4 gene had a fold regulation of 
1.747 at 24hrs, and was up-regulated to 3.184 fold at 72hrs.  There was a fold regulation 
of -1.176 at 24hrs for the IFNA2 gene, which was up-regulated to 2.522 fold at 72hrs.  At  
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24hrs the IFNG gene had a fold regulation of 1.506 and a fold regulation of 2.852 at 
72hrs. 
  
Table 4. Fold regulation values for the genes relevant to autophagy induction by 
intracellular pathogens following infection of neuronal cells with C. pneumoniae for 
24hrs and 72hrs. 
 
 
Fold Regulation – Autophagy Induction 
by Intracellular Pathogens 
  24hr inf 72hr inf 
IFNA2 -1.176 2.522 
IFNA4 1.747 3.184 
IFNG 1.506 2.852 
 
 
 
 
 
 
Figure 6. Fold regulation of the genes associated with autophagy induction by  
intracellular pathogens following infection of neuronal cells with C. pneumoniae for 
24hrs and 72hrs. Genes with a significant p-value are indicated with asterisks. 
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3.6 Autophagy Genes Following Staurosporine Treatment 
 
The neuronal cells were induced into apoptosis with 1µM staurosporine to 
compare the effects of C. pneumoniae and staurosporine in neuronal cells on the key 
genes involved in autophagy.  As seen in figure 7 and table 5, the treatment of infected 
neuronal cells with staurosporine resulted in minimal up-regulation of the key genes 
involved in autophagy, which include ATG4C, ATG9A, BECN1, and DRAM, at 24hrs 
and 72hrs.  For all of the key autophagy genes following staurosporine treatment, except 
for ATG9A, there was a greater level of expression at 24hrs than at 72hrs.  For example, 
with staurosporine the ATG4C gene had a fold regulation of 1.999 at 24hrs and 1.485 at 
72hrs.  In contrast, the ATG9A gene had a fold regulation of 1.481 at 24hrs with 
staurosporine and a fold regulation of 2.107 after 72hrs with staurosporine.  At 72hrs, the 
fold regulation of the key autophagy genes following treatment of infected neuronal cells 
with staurosporine was similar to the fold regulation of the key autophagy genes from the 
untreated infected neuronal cells. 
 
Table 5. Fold regulation values for the key autophagy genes following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs and treatment with staurosporine 
for 3hrs to induce apoptosis.   
 
 
Fold Regulation of Autophagy Genes 
  24hr inf 72hr inf 24hr inf +stauro 72hr inf +stauro 
ATG4C -25.773 2.738 1.999 1.485 
ATG9A -1.067 1.637 1.481 2.107 
BECN1 -3.662 1.532 1.767 1.690 
DRAM -2.680 1.575 1.654 1.563 
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Figure 7. Fold regulation of the key genes involved in autophagy following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs and treatment with staurosporine 
for 3hrs to induce apoptosis. Genes with significant p-values are indicated with asterisks.  
 
 
 
3.7 Autophagy Machinery Components 
 
The RT
2
-PCR array includes multiple genes involved in the autophagy process.  
The autophagy genes are divided into two categories, such as genes for autophagy 
machinery components and genes involved in the regulation of autophagy.  Autophagy 
machinery components refer to genes associated with autophagic vacuole formation, 
protein targeting to the membrane/vacuole, protein transport, linking of the 
autophagosome to the lysosome, and protease activity (43).   
A majority of the genes associated with autophagy machinery components were 
up-regulated in the neuronal cells infected with C. pneumoniae for 24hrs and 72hrs, with 
greater up-regulation after 72hrs (Figure 8 and Table 6).  The primary genes involved  
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with autophagic vacuole formation include AMBRA1, ATG16L1, and MAP1LC3B.  The 
protein encoded by the AMBRA1 gene is associated with autophagy by controlling 
turnover of proteins (38), and the Ambra1 protein interacts with the Beclin 1-Class III 
PI3K complex, which is a part of the autophagy signaling pathway (18).  The ATG16L1 
gene encodes a protein that is part of a large protein complex necessary for autophagy, 
while the MAP1LC3B gene encodes a protein that is a subunit of the neuronal 
microtubule-associated MAP1A and MAP1B proteins (39).  At 24hrs, the AMBRA1 
gene was down-regulated whereas the ATG16L1 and MAP1LC3B genes were up-
regulated.  The fold regulation for the MAP1LC3B gene was 2.131 at 24hrs and 1.216 at 
72hrs.  The ATG16L1 gene had a fold regulation of 1.456 at 24hrs, and an increase in 
fold regulation to 2.336 after 72hrs.  In contrast to the general trend observed for the 
genes implicated in autophagy machinery components, the AMBRA1 gene was down-
regulated to 2.112 fold at 24hrs, and was up-regulated to 1.375 fold at 72hrs.  
 The predominant genes associated with protein targeting to the 
membrane/vacuole and protease activity are ATG4A and ATG4D (Figure 8 and Table 6).  
The ATG4A and ATG4D genes encode proteins that are cysteine proteases, which are 
necessary for autophagy (38).  Both genes were up-regulated at the 24hr and 72hr time 
points, with greater up-regulation after 72hrs.  At 24hrs, the ATG4A gene had a fold 
regulation of 1.465, which was up-regulated to 2.115 fold at 72hrs.  The ATG4D gene 
had a 1.228 fold regulation at 24hrs and a fold regulation of 1.422 at 72hrs.   
The ATG4A and ATG4D genes are also involved in protein transport, as are the 
ATG10, ATG16L1, and RAB24 genes (Figure 8 and Table 6).  The ATG10 gene encodes  
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an E2-like enzyme, which is involved in ubiquitin-like modifications, such as the 
conjugation of Atg12 and Atg5 for autophagosome formation (38).  The protein encoded 
by the RAB24 gene is a GTPase, which is a Ras-related protein that is implicated in the 
regulation of intracellular protein trafficking (38).  All of these genes were up-regulated 
at 24hrs and 72hrs following infection with C. pneumoniae, except for the ATG10 gene, 
which was slightly down-regulated at 24hrs.  The RAB24 gene had a fold regulation of 
2.517 at 24hrs, which decreased to a fold regulation of 1.049 at 72hrs.  After 24hrs, the 
fold regulation for the ATG10 gene was -1.121, which was up-regulated to 5.360 fold at 
72hrs.   
 FAM176A is a gene involved in the linking of the autophagosome to the 
lysosome (Figure 8 and Table 6).  The FAM176A gene is also known as the TMEM166 
gene (43), which is a gene that encodes a lysosome and endoplasmic reticulum-associated 
membrane protein (44).  At both time points, the FAM176A gene was up-regulated, with 
greater up-regulation after 72hrs, following infection of the neuronal cells with C. 
pneumoniae.  For the 24hr time point, the FAM176A gene had a fold regulation of 2.561.  
After 72hrs, the FAM176A gene had a fold regulation of 2.854.   
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Table 6. Fold regulation values of genes associated with autophagy machinery 
components following infection of neuronal cells with C. pneumoniae for 24hrs and 
72hrs.   
 
Fold Regulation-Autophagy Machinery Components 
  24hr inf 72hr inf 
AMBRA1 -2.112 1.375 
ATG10 -1.121 5.360 
ATG16L1 1.456 2.336 
ATG4A 1.465 2.115 
ATG4D 1.228 1.422 
MAP1LC3B 2.131 1.216 
RAB24 2.517 1.049 
FAM176A 2.561 2.854 
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Figure 8. Fold regulation for genes associated with autophagy machinery components 
following infection of neuronal cells with C. pneumoniae for 24hrs and 72hrs. Genes 
with significant p-values are indicated with asterisks. 
 
 
3.8 Regulation of Autophagy 
 There are autophagy genes that belong to the regulation of autophagy category, 
which refers to genes that are involved with autophagy in response to other intracellular 
signals, co-regulators of autophagy and apoptosis, or co-regulators of autophagy and the 
cell cycle.  After infection of the neuronal cells with C. pneumoniae, the genes associated 
with autophagy in response to other intracellular signals, such as EIF4G1, GAA, ULK2, 
and UVRAG, showed a greater level of expression after 72hrs than at 24hrs (Figure 9 and 
Table 7).  The EIF4G1 gene encodes a protein that is part of a multi-subunit protein 
complex, which is involved in the initiation phase of protein synthesis (38).  The GAA  
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gene encodes acid alpha-glucosidase, which is necessary for the degradation of glycogen 
to glucose in lysosomes (38).  The protein encoded by the ULK2 gene is important during 
the activation of autophagy (45).  The UVRAG gene encodes a protein that activates the 
Beclin 1-PI(3)KC3 complex to induce autophagy (38).  At 24hrs, the EIF4G1 and GAA 
genes were up-regulated, and the ULK2 and UVRAG genes were down-regulated.  At 
72hrs, the EIF4G1, GAA, and UVRAG genes were up-regulated, whereas the ULK2 
gene was greatly down-regulated.  For example, the GAA gene had a fold regulation of 
1.527 at 24hrs, which was up-regulated to 2.946 fold at 72hrs.  In contrast, the ULK2 
gene had a fold regulation of -1.591 at 24hrs, which was down-regulated to 8.183 fold at 
72hrs.   
 
Table 7. Fold regulation values for genes relevant to autophagy in response to 
intracellular signals following infection of neuronal cells with C. pneumoniae for 24hrs 
and 72hrs. 
 
Fold Regulation - Autophagy in Response to Intracellular 
Signals 
  24hr inf 72hr inf 
ARSA -3.416 1.733 
EIF4G1 2.391 2.725 
ESR1 -1.201 2.207 
GAA 1.527 2.946 
PIK3C3 -1.227 3.088 
PIK3R4 2.089 2.726 
PRKAA2 2.139 2.023 
TMEM74 1.876 2.998 
TMEM77 2.263 1.914 
ULK2 -1.591  -8.183 
UVRAG -2.440 1.611 
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Figure 9. Fold regulation for genes associated with autophagy in response to intracellular 
signals following infection of neuronal cells with C. pneumoniae for 24hrs and 72hrs. 
Genes with significant p-values are indicated with an asterisk.  
 
 
Following infection of neuronal cells with C. pneumoniae, as seen in Figure 10 
and Table 8, the BAX, CDKN1B, TGFB1, and TP73 genes are co-regulators of 
autophagy and the cell cycle, which had greater expression at 24hrs than at 72hrs, except 
for the CDKN1B gene.  The expression of the BAX gene is regulated by the tumor 
suppressor P53.  The BAX gene encodes a BCL2 family protein that binds BCL2 to 
prevent BCL2’s anti-apoptotic activity (38).  The CDKN1B gene encodes a protein that 
regulates cell cycle progression by arresting the cell cycle at G1 (38).  The protein 
encoded by the TGFB1 gene is a member of the transforming growth factor family of  
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cytokines (38).  The TP73 gene encodes a member of the p53 family that is part of the 
apoptosis response in the cell to stress (38).  At 24hrs, there was a fold regulation of 
2.136 for the BAX gene, 2.807 for the TGFB1 gene, and 3.252 for the TP73 gene.  The 
fold regulation at 72hrs was 1.965 for the BAX gene, 2.580 for the TGFB1 gene, and  
-5.247 for the TP73 gene.  In contrast to the general trend observed for the previous 
genes, the CDKN1B gene had a fold regulation of -2.858 at 24hrs, which increased to  
-1.168 fold at 72hrs.   
 
Table 8. Fold regulation values for genes involved in the co-regulation of autophagy and 
the cell cycle and/or the co-regulation of autophagy and apoptosis following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs. 
 
 
Fold Regulation - Co-Regulators 
  24hr inf 72hr inf 
AKT1 -3.542 1.286 
BAX 2.136 1.965 
BCL2 -1.055 1.399 
CDKN1B -2.858 -1.168 
CDKN2A 1.889 2.398 
CLN3 1.495 2.238 
PRKAA1 -1.230 1.314 
PTEN 3.890 1.245 
SQSTM1 -7.375 2.100 
TGFB1 2.807 2.580 
TGM2 -1.619 2.162 
TNF 4.625 1.640 
TP73 3.252 -5.247 
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Figure 10. Fold regulation for genes involved in the co-regulation of autophagy and the 
cell cycle and/or the co-regulation of autophagy and apoptosis following infection of 
neuronal cells with C. pneumoniae for 24hrs and 72hrs. Genes with significant p-values 
are indicated with asterisks. 
 
 
 
3.9 Co-regulation of Autophagy and Apoptosis 
 
 The key genes that are co-regulators of autophagy and apoptosis include BCL2, 
PRKAA1, SQSTM1, and TGM2.  After infection of the neuronal cells with  
C. pneumoniae, these genes were down-regulated at 24hrs and up-regulated at 72hrs 
(Figure 11 and Table 9).  The BCL2 gene is involved in both apoptosis and autophagy 
regulation (18).  The BCL2 gene encodes an outer mitochondrial membrane protein that 
suppresses apoptosis (38).  The BCL2 protein can also bind with the Beclin 1 protein to  
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prevent Beclin 1 from inducing autophagy (18).  The PRKAA1 gene encodes a catalytic 
subunit of the 5’-prime-AMP activated protein kinase (AMPK), which can sense the 
cell’s energy levels (38).  The SQSTM1 gene encodes a multifunctional protein that binds 
ubiquitin and regulates the activation of the NFKB signaling pathway (38).  The TGM2 
gene encodes a transglutaminase enzyme that seems to be involved in apoptosis (38).  
The BCL2 gene had a fold regulation of -1.055 at 24hrs and a fold regulation of 1.399 at 
72hrs.  The SQSTM1 gene had a fold regulation of -7.375 at 24hrs, which increased to 
2.100 fold at 72hrs.   
 
Table 9. Fold regulation values for the key genes involved in the co-regulation of 
autophagy and apoptosis following infection of neuronal cells with C. pneumoniae for 
24hrs and 72hrs. 
 
 
Fold Regulation - Co-regulators of Autophagy and Apoptosis 
  24hr inf 72hr inf 
BCL2 -1.055 1.399 
PRKAA1 -1.230 1.314 
SQSTM1 -7.375 2.100 
TGM2 -1.619 2.162 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
42 
 
 
 
 
 
Figure 11. Fold regulation for the key genes involved in the co-regulation of autophagy 
and apoptosis following infection of neuronal cells with C. pneumoniae for 24hrs and 
72hrs. Genes with significant p-values are indicated with asterisks. 
 
 
 
3.10 Co-regulation of Autophagy and Apoptosis Following Staurosporine Treatment 
 
 In order to differentiate the effects exerted by C. pneumoniae in neuronal cells on 
the key genes involved in the co-regulation of autophagy and apoptosis, the infected 
neuronal cells were induced into apoptosis with 1µM staurosporine.  As seen in figure 12 
and table 10, the addition of staurosporine to neuronal cells had varied results for the key 
genes involved in the co-regulation of autophagy and apoptosis, which include BCL2, 
PRKAA1, SQSTM1, and TGM2.  At 24hrs the BCL2 and PRKAA1 genes were up-
regulated, whereas the SQSTM1 and TGM2 genes were down-regulated.  At 72hrs, the 
BCL2, PRKAA1, and SQSTM1 genes were up-regulated, whereas the TGM2 gene was  
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down-regulated.  The BCL2 gene had a fold regulation of 2.046 at 24hrs, which 
decreased to a 1.208 fold regulation at 72hrs.  The TGM2 gene had a fold regulation of 
-2.449 at 24hrs and -1.133 at 72hrs.    
 
Table 10. Fold regulation values for the key genes involved in the co-regulation of 
autophagy and apoptosis following infection of neuronal cells with C. pneumoniae and 
treatment with staurosporine for 3hrs to induce apoptosis. 
  
Fold Regulation - Co-regulators of Autophagy and Apoptosis 
  24hr inf 72hr inf 24hr inf +stauro 72hr inf +stauro 
BCL2 -1.055 1.399 2.046 1.208 
PRKAA1 -1.230 1.314 3.150 1.580 
SQSTM1 -7.375 2.100 -1.874 1.244 
TGM2 -1.619 2.162 -2.449 -1.133 
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Figure 12. Fold regulation for the key genes involved in the co-regulation of autophagy 
and apoptosis following infection of neuronal cells with C. pneumoniae for 24hrs and 
72hrs and treatment with staurosporine for 3hrs to induce apoptosis. Genes with 
significant p-values are indicated with asterisks.  
 
 
3.11 Trends in Autophagy and Apoptosis Data 
 Following infection of the neuronal cells with C. pneumoniae, the general trend 
demonstrated by the genes involved in both apoptosis and autophagy was a  
down-regulation of expression at 24hrs followed by an up-regulation at 72hrs.  In 
contrast, following treatment of infected neuronal cells with staurosporine to induce 
apoptosis, the trends in gene regulation were different for the autophagy and apoptosis 
genes.  After the infected neuronal cells were incubated with staurosporine, the genes  
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involved in autophagy were up-regulated at both 24hrs and 72hrs; whereas there was an 
up-regulation of gene expression at 24hrs followed by a down-regulation of gene 
expression at 72hrs for the genes involved in apoptosis.  Uninfected neuronal cells at 
24hrs and 72hrs were the controls for the infected neuronal cells.  Uninfected neuronal 
cells incubated with staurosporine at 24hrs and 72hrs were the controls for the infected 
neuronal cells incubated with staurosporine.  
 From the 84 genes analyzed on the RT
2
-PCR array, we chose to observe 43 of 
these genes more closely.  After infection of the neuronal cells with C. pneumoniae, 7 of 
the 43 genes had significant p-values.  Of these 7 genes, two are involved in apoptosis, 
which include the FAS and SQSTM1 genes. The other 5 were genes involved in 
autophagy, including AKT1, AMBRA1, ATG4C, GAA, and IFNA4.  The ATG4C, FAS, 
and GAA genes had p-values approaching significance that were between 0.05 and 0.10.  
The AKT1, AMBRA1, ATG4C, and SQSTM1 genes had significant p-values at 24hrs 
post-infection, whereas the FAS, GAA, and IFNA4 genes had significant p-values at 
72hrs post-infection.       
 Following treatment of neuronal cells with staurosporine, an apoptosis inducer, to 
differentiate the effects of C. pneumoniae, 23 of the 43 genes that were observed had 
significant p-values.  The PRKAA2 gene at 24hrs post-infection and the ATG4D and 
TGFB1 genes at 72hrs had p-values approaching significance that were between 0.05 and 
0.10.  About half of the 23 genes had significant p-values at both 24hrs post-infection and 
72hrs post-infection.  A majority of the 23 genes had significant p-values at 24hrs post- 
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infection.  Of the 23 genes, 7 genes are involved in apoptosis and 16 genes are involved 
in autophagy.      
 
3.12 Summary of Functions of Gene Products 
Table 11. Functions of the gene products of each gene that was discussed in the results 
section. 
 
 
Gene   Functions of Gene Products 
    
BAK1 Contributes to the mitochondrial pathway of apoptosis (37) 
BNIP3 Contributes to the mitochondrial pathway of apoptosis (37) 
CASP8 Initiator caspase that induces apoptosis via the death receptor pathway (37) 
FAS Death receptor that induces apoptosis via the death receptor pathway (38) 
NFKB1 Inhibits apoptosis and is a nuclear transcription factor (17) 
    
ATG4C Important for autophagosome formation (39, 40) 
ATG9A Important for autophagosome formation (39, 40) 
BECN1 Important for autophagosome formation (39, 40) 
DRAM Lysosomal protein that is a damage-regulated autophagy modulator (41) 
    
IFNA2 Cytokine that stimulates immune cells (42) 
IFNA4 Cytokine that stimulates immune cells (42) 
IFNG Cytokine that activates macrophages (38) 
    
AMBRA1 Controls protein turnover (38); Interacts with Beclin 1-Class III PI3K complex (18)  
ATG10 E2-like enzyme that is involved in the conjugation of Atg12 and Atg5 for  
  autophagosome formation (38) 
ATG16L1 Part of large protein complex necessary for autophagy (39) 
ATG4A Cysteine protease that is necessary for autophagy (38) 
ATG4D Cysteine protease that is necessary for autophagy (38) 
MAP1LC3B Subunit of the neuronal microtubule-associated MAP1A and MAP1B proteins (39) 
RAB24 GTPase protein that is implicated in the regulation of intracellular protein trafficking (38) 
FAM176A Lysosome and endoplasmic reticulum-associated membrane protein (44) 
    
ARSA Lysosomal enzyme, arylsulfatase A, that processes sulfatides in the cell membrane (46) 
 
                                                                                                                (cont. on next page) 
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Table 11 (cont.) 
 
EIF4G1 Involved in the initiation phase of apoptosis (38) 
ESR1 Estrogen receptor important for the binding of hormones (47)  
GAA Degradation of glycogen to glucose in lysosomes (38) 
PIK3C3 Important in the transport of lysosomal enzyme precursors to lysosomes (48) 
PIK3R4 Involved in membrane trafficking within the endocytic pathway (38) 
TMEM74 May be important for stimulating autophagy during cell stress (49)  
TMEM77 Vital for p53-mediated apoptosis (50) 
ULK2 Important during the activation of autophagy (45) 
UVRAG Activates Beclin 1-PI(3)KC3 complex to induce autophagy (38) 
    
AKT1 Important for the normal functioning of the AKT-mTOR signaling pathway (51)  
BAX Binds to BCL2 to prevent BCL2's anti-apoptotic activity (38) 
CDKN1B Regulates cell cycle progression by arresting the cell cycle at G1(38) 
CDKN2A Can stop the cell cycle in the G1 and G2 phases; induces apoptosis (52) 
CLN3  May be important in the proper functioning of the lysosome (46) 
PTEN Triggers cells to undergo apoptosis (46) 
TGFB1 Member of the transforming growth factor family of cytokines (38) 
TNF Cytokine involved in the induction of apoptosis (53) 
TP73 Part of the apoptosis response in the cell to stress (38) 
    
BCL2 Inhibition of apoptosis autophagy pathways (18) 
PRKAA1 Subunit of AMPK that can sense the cell's energy levels (38) 
SQSTM1 Binds ubiquitin; regulates activation of the NFKB signaling pathway (38) 
TGM2 Transglutaminase enzyme that seems to be involved in apoptosis (38) 
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Chapter 4: Discussion 
 
 
 
4.1 Effects of Chlamydia pneumoniae Infection on Apoptosis and Autophagy 
 
Previous studies have described the pathogen hypothesis of AD in which  
C. pneumoniae is implicated as a factor associated with the pathology observed in AD.  
In the landmark study for the pathogen hypothesis by Balin et al. 1998, C. pneumoniae 
was found to be associated with AD pathology in neuronal cells from AD brains (28).  
From this study, it was determined that C. pneumoniae DNA was more prevalent in 
samples of brain tissue from post-mortem AD brains than from brain tissue samples of 
those who did not have AD.   
C. pneumoniae has been shown to manipulate its host cell’s genetic machinery 
(28); however, presently, there are no studies that have evaluated the role that  
C. pneumoniae plays in altering the expression of genes in neuronal cells that are 
associated with apoptosis and autophagy.  Since several studies have shown that  
C. pneumoniae inhibits apoptosis in monocytes and neuronal cells (34), we investigated 
C. pneumoniae’s ability to alter the genetic regulation of apoptosis and autophagy.  
Apoptosis and autophagy have been recognized as key events involved in the pathology 
of AD (34, 21, 24).  Our experimental paradigm was to determine if infection of neuronal 
cells by  
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C. pneumoniae results in changes in gene expression in the apoptotic or autophagic 
pathways consistent with previous work by others (21, 34) indicating that these pathways 
are affected in Alzheimer’s disease.  
This study was proposed to examine the detailed events at the level of gene 
expression, such as suppression of apoptosis or induction of autophagy, which may allow  
the neuronal cell to accumulate the cytotoxic form of β-amyloid.  Since C. pneumoniae 
has been implicated as a trigger for AD and neuronal cells are thought to be a source of 
abnormal amyloid production, SKNMC neuronal cells were infected with C. pneumoniae 
and analyzed for changes in apoptosis and autophagy gene expression using RT
2
-PCR 
arrays.  Staurosporine, an initiator of apoptosis, was utilized to differentiate if  
C. pneumoniae is solely suppressing apoptosis gene expression or alternatively increasing 
autophagy gene expression.  
 
4.2 Apoptosis Genes 
The general trend observed for the key apoptosis genes was an initial  
down-regulation of gene expression at 24hrs followed by an increase in gene expression 
at 72hrs.  For the genes involved in the mitochondrial pathway of apoptosis, BAK1 and 
BNIP3 (37), this trend indicates that apoptosis through the mitochondrial pathway may 
be suppressed at 24hrs and then activated by the cell at 72hrs.  In contrast, the FAS gene 
was up-regulated at 24hrs and 72hrs.  The FAS gene encodes the death receptor that 
interacts with proteins to initiate apoptosis (38), so the results demonstrate that the FAS 
gene may have been up-regulated in order to initiate the apoptosis pathway following the  
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C. pneumoniae infection.  The CASP8 gene encodes a protein that is down-stream of the 
FAS receptor in the death receptor pathway of apoptosis and was down-regulated at  
24hrs and 72hrs; one might speculate that the death receptor signaling pathway may not 
be activated at the protein level to carry out apoptosis.    
The NFKB1 gene encodes a protein that is anti-apoptotic and is a nuclear 
transcription factor (17).  In other cell lines, such as monocytes, the expression of the 
NFKB1 gene was increased following infection with C. pneumoniae (Dr. B.J. Balin and 
Charlie Lim MS, unpublished observations).  However, in the neuronal cells, there was a 
decrease in expression of the NFKB1 gene at both 24hrs and 72hrs. Since the NFKB1 
gene encodes a nuclear transcription factor, a decrease in NFKB1 gene expression in 
neuronal cells may lead to the shutdown of other genes that could assist the neuronal cell 
in eliminating the C. pneumoniae infection. 
 
4.3 Apoptosis Genes Following Staurosporine Treatment 
Following treatment of infected neuronal cells with 1µM staurosporine to induce 
apoptosis, the key apoptosis genes were up-regulated at 24hrs, which was followed by a 
decrease at 72hrs.  The genes for both the death receptor and mitochondrial pathways of 
apoptosis were up-regulated at 24hrs, which suggests that the neuronal cells may have 
been stimulated to undergo apoptosis through each signaling pathway.  The decrease in 
expression after treatment with staurosporine at 72hrs post-infection may be the result of 
C. pneumoniae suppressing apoptosis in order to maintain the infection in the host.  The  
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NFKB1 gene encodes a transcription factor that can also be anti-apoptotic and was up-
regulated at both 24hrs and 72hrs post-infection and after staurosporine treatment.  These  
results further indicate that apoptosis may have been inhibited after 72hrs by the  
C. pneumoniae infection. 
 
4.4 Autophagy Genes 
Since the apoptosis and autophagy pathways are connected, the genes involved in 
autophagy were also screened following infection with C. pneumoniae for 24hrs and 
72hrs.  The general trend for the key genes implicated in autophagy was a down-
regulation of gene expression at 24hrs followed by an up-regulation of gene expression at 
72hrs.  The ATG9A and BECN1 genes are both involved in the formation of autophagic 
vacuoles, and the DRAM gene is involved in the linking of the autophagosome to the 
lysosome (43).  These results indicate that autophagic vacuole formation and linking of 
the autophagosome and lysosome may be suppressed at 24hrs, but are induced after 72hrs 
infection with C. pneumoniae.  The ATG4C gene encodes a protein with multiple 
functions; specifically autophagic vacuole formation, protein targeting to the 
membrane/vacuole, protein transport, and protease activity.  The up-regulation of the 
ATG4C gene may indicate that the cell is trying to induce any one of these autophagy 
related functions following infection with C. pneumoniae for 72hrs. 
  
 
 
52 
 
 
4.5 Genes Involved in Autophagy Induction by Intracellular Pathogens 
The IFNA2, IFNA4, and IFNG genes are involved in autophagy induction when 
an intracellular pathogen, such as C. pneumoniae, has infected a cell (43).  The general 
trend for these autophagy genes is up-regulation of gene expression at 24hrs followed by  
an even greater increase in gene expression at 72hrs, with the exception of the IFNA2 
gene, which was down-regulated at 24hrs.  This data demonstrates that at 24hrs there may  
be slight induction of autophagy, and at 72hrs autophagy induction may be further 
increased to try and eliminate the C. pneumoniae infection.      
 
4.6 Autophagy Genes Following Staurosporine Treatment    
 Previous studies have shown that induction of apoptosis with staurosporine 
following infection with C. pneumoniae actually resulted in an inhibition of apoptosis, 
indicating that C. pneumoniae can control this process (34).  Therefore, our experiments 
were designed to induce apoptosis with 1µM staurosporine after infection with C. 
pneumoniae to see if autophagy would be initiated instead.  The general trend following 
staurosporine treatment for the key autophagy genes, which include ATG4C, ATG9A, 
BECN1, and DRAM, was an up-regulation of gene expression at 24hrs and 72hrs, with 
greater expression at 24hrs.  The autophagic vacuole formation, linking of the 
autophagosome to lysosome, and protease activity functions of the key autophagy genes 
appeared to be induced at 24hrs and 72hrs.  The addition of staurosporine to the infected 
neuronal cells resulted in a decrease in regulation of the key apoptosis genes and up-
regulation of the key autophagy genes at 72hrs.  The data from the 24hr and 72hr time  
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points indicates that treatment of infected neuronal cells with staurosporine may 
eventually suppress apoptosis, and induce autophagy instead.  From these experiments, 
we can speculate that a C. pneumoniae infection may be utilizing autophagy for the 
survival of the cell.  
 
4.7 Autophagy Machinery Components 
There were multiple autophagy genes included in the RT
2
-PCR arrays that were 
either associated with autophagy machinery components, which are genes implicated in 
the formation and clearance of autophagic vacuoles, or with genes involved involved in 
the regulation of autophagy.  Following infection with C. pneumoniae, a majority of the 
genes that were related to the formation and clearance of autophagic vacuoles were up-
regulated at 24hrs and 72hrs, with the exception of the AMBRA1 and ATG10 genes, 
which were down-regulated at 24hrs.  The AMBRA1, ATG16L1, and MAP1LC3B genes 
are involved in autophagic vacuole formation.  The ATG4A and ATG4D genes are 
associated with protein targeting to the membrane/vacuole, protease activity, and protein 
transport.  The ATG10, ATG16L1, and RAB24 genes are also involved in protein 
transport.  The FAM176A gene is implicated in the linking of the autophagosome with 
the lysosome.  The general trend of up-regulation of gene expression at 24hrs and 72hrs 
indicates that there may have been an induction of autophagic vacuole formation, protein 
targeting to the membrane/vacuole, protease activity, protein transport, and linking of the 
autophagosome to the lysosome.  However, the AMBRA1 and ATG10 genes were down-
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regulated at 24hrs, which may indicate that these genes were slower to respond to the 
infection.  
 
4.8 Regulation of Autophagy 
 The genes related to the regulation of autophagy are either involved in autophagy 
in response to other intracellular signals, the co-regulation of autophagy and apoptosis, or  
the co-regulation of autophagy and the cell cycle.  There are several genes associated 
with autophagy in response to other intracellular signals.  Following infection of the 
neuronal cells with C. pneumoniae for 24hrs, approximately half of these genes were 
down-regulated, while the other half of the genes in this group were up-regulated.  All of 
these genes were up-regulated after infection for 72hrs, except for the ULK2 gene.  The 
results at 24hrs indicate that the up- and down-regulation of these genes was offset so that 
autophagy may not have been induced due to interference from other intracellular signals.  
At 72hrs, the upward trend in gene regulation demonstrates that autophagy may have 
been induced in response to other intracellular signals occurring in the cell.  One such 
intracellular signal may be low nutrient levels in the cell, such as amino acids and glucose 
(20).            
Following infection of the neuronal cells with C. pneumoniae, the genes involved 
in the co-regulation of autophagy and the cell cycle were up-regulated at 24hrs and at 
72hrs, with the exception of the CDKN1B gene and the TP73 gene at 72hrs.  These 
results indicate that at 24hrs the infection may be influencing the cell cycle and  
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autophagy.  Based on the data from 72hrs, there appeared to be a balance in the 
regulation of autophagy and the cell cycle resulting in very little change.  
 A majority of the co-regulators of autophagy and apoptosis were up-regulated at 
24hrs and 72hrs following infection of the neuronal cells with C. pneumoniae, with the 
exception of the AKT1 gene at 24hrs and the TP73 gene at 72hrs.  For most of these 
genes, there was greater up-regulation at 24hrs than at 72hrs.  The BAX, TNF, and TP73  
genes are involved in the co-regulation of apoptosis, whereas the AKT1, CLN3, PTEN, 
and TGFB1 genes are involved in autophagy.  The data suggests that at 24hrs apoptosis  
may have been induced in the cell, but at 72hrs there may have been suppression of 
apoptosis because the TP73 gene was greatly down-regulated.  In contrast, there may 
have been some suppression of autophagy at 24hrs since the AKT1 gene was down-
regulated, although our data indicates that the autophagy genes may have been induced at 
72hrs.   
 
4.9 Co-regulation of Autophagy and Apoptosis 
 In the RT
2
-PCR array, there were many genes involved in the co-regulation of 
autophagy and apoptosis; however, we found the most interesting genes in this group to 
be BCL2, PRKAA1, SQSTM1, and TGM2.  In this instance, the co-regulation of 
autophagy and apoptosis refers to genes that encode proteins, which could have an effect 
on both the autophagy and apoptosis pathways.  For instance, the protein encoded by the 
BCL2 gene inhibits autophagy through the inhibition of the Beclin1 protein; and inhibits 
apoptosis by inhibiting the BH3-only proteins, such as Bad and Bnip3 (18).  Following  
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infection of the neuronal cells with C. pneumoniae, these genes were down-regulated at 
24hrs and up-regulated at 72hrs.  The results indicate that both autophagy and apoptosis 
may have been suppressed at 24hrs, especially apoptosis since the expression of the 
SQSTM1 gene was significantly decreased.  The data shows that autophagy and 
apoptosis may be induced at 72hrs.  However, the BCL2 gene is slightly up-regulated at 
72hrs and the SQSTM1 and TGM2 genes, which encode proteins that have more of an  
effect on apoptosis (38), had greater up-regulation than the other genes in this group.  
These results may indicate that apoptosis may have been more strongly induced than  
autophagy at 72hrs, although our data analysis for other genes does not support this 
conclusion.  The RT
2
-PCR arrays analyze the level of gene expression, not protein 
expression, so protein analysis would have to be performed to determine the effects of C. 
pneumoniae on apoptosis and autophagy with regards to the co-regulatory proteins 
encoded by these genes.  
 
4.10 Co-regulation of Autophagy and Apoptosis Following Staurosporine Treatment 
 In order to differentiate the effects of C. pneumoniae in neuronal cells on the key 
genes involved in the co-regulation of autophagy and apoptosis, the infected neuronal 
cells were treated with 1µM of staurosporine to induce apoptosis.  At 24hrs, the BCL2 
and PRKAA1 genes were up-regulated, whereas the SQSTM1 and TGM2 genes were 
down-regulated.  A majority of these genes were up-regulated at 72hrs, except for TGM2.    
The up-regulation of gene expression for PRKAA1 and BCL2 suggests that following 
infection with C. pneumoniae and staurosporine treatment there may have been an  
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induction of autophagy at 24hrs and 72hrs with a slight decrease of induction at 72hrs.  
Based on the data for the SQSTM1 and TGM2 genes, apoptosis may have been 
suppressed at 24hrs and at 72hrs post-infection and after staurosporine treatment.   
 
4.11 Conclusions 
Autophagy and apoptosis are complex cellular processes that can enhance a cells 
survival or efficiently induce cell death in a controlled manner as a response to stimuli 
such as a bacterial infection to evade an inflammatory response.  The autophagy and 
apoptotic processes are currently being investigated in AD as potential cellular events 
that may lead to neurodegeneration.  In addition, there is also a complex relationship 
between autophagy and the endosomal/lysosomal process in Alzheimer’s disease.  As is 
demonstrated in figure 13, we speculate that following intracellular C. pneumoniae 
infection; the organism may escape autophagolysosomal and lysosomal fusion and 
therefore subvert degradation by lysosomal proteases creating a host friendly 
environment for intracellular pathogen growth within inclusions. In order for the C. 
pneumoniae to survive, the organism uses ATP produced by the mitochondria of the host 
cell (54), which may lead to damage of the mitochondria in the infected cell.  The 
presence of damaged mitochondria could lead to the induction of autophagy for 
degradation of these damaged organelles.  Our results did show an increase in the 
expression of genes involved in autophagy after 72hrs infection with C. pneumoniae, 
which may indicate that autophagy was induced. An increase in autophagy leads to an 
increase in lysosomal processing, which may lead to more endosomal-lysosomal fusion.   
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It has been determined that β-amyloid is produced in the endosome (12), so an increase in 
endosomal-lysosomal fusion may lead to increased β-amyloid production. 
 
 
 
 
Figure 13. A model demonstrating the involvement of the autophagy pathway following 
C. pneumoniae infection. This model is a modification of a diagram from: Nixon, R. A. 
(2007). Autophagy, amyloidogenesis, and Alzheimer’s disease. Journal of Cell Science, 
120(23), 4081-4091. This model was proposed by Drs. Denah Appelt, Brian Balin, and 
Susan Hingley. 
 
As seen in Figure 14, previous studies have shown that following infection with 
C. pneumoniae in BALB/c mice, processing of amyloid precursor protein occurred in the 
infected cell to produce β-amyloid (29).  Infection with C. pneumoniae has also been 
shown to inhibit apoptosis (34), and the results from these experiments have 
demonstrated at the level of gene expression that autophagy may be inhibited initially at 
24hrs post-infection, but seemed to be induced at 72hrs post-infection.  The infection  
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with C. pneumoniae and possible induction of autophagy may be responsible for the 
production of free β-amyloid in the extracellular space between neurons.  The free  
β-amyloid could then induce autophagy and apoptosis in neighboring cells, which may 
ultimately lead to neuronal cell death as seen in AD.  The experiments in this study 
analyzed C. pneumoniae’s effects on apoptosis and autophagy at the level of gene 
expression.  Further investigation with experiments at the level of protein expression is in 
progress. 
 
 
 
 
 
Figure 14. Proposed autophagy and apoptosis model for AD following infection with C. 
pneumoniae for induction of amyloid. Model proposed by Drs. Denah Appelt, Brian 
Balin, and Susan Hingley. 
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4.12 Future Directions 
 
Future experiments need to be conducted to further prove that autophagy is 
induced in neuronal cells after infection with C. pneumoniae. It would also be interesting 
to observe the effects of autophagy induction and C. pneumoniae infection on the levels  
of gene expression at 48hr, 72hr, and 5 day time points to compare to the 24 and 72hr 
experiments profiled in this study.  There are several compounds, such as rapamycin and 
vinblastine that induce autophagy.  Specifically, treatment with vinblastine slows the 
fusion of autophagosomes with lysosomes, which would allow investigation of 
autophagy dysfunction as it applies to AD (24).  Considering that the RT
2
-PCR arrays 
only allow the analysis of gene expression levels, proteins that parallel the genes affected 
following infection of neuronal cells should be evaluated using immunocytochemistry 
and western analysis to clarify the effects on the autophagy pathway.  The information 
gained from the proposed future experiments will enhance our knowledge of the 
involvement of infection in triggering the events associated with neurodegeneration seen 
in AD.  
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